Survival in Acute Non-lymphocytic Leukaemia Following Breast Cancer

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1990 Nov 1

PMID 2250264

Authors

S D Kaster

F F Holmes

Affiliations

Soon will be listed here.

Abstract

Acute non-lymphocytic leukaemia (ANLL) occurs with increased frequency in women with previously diagnosed breast cancer. Adjuvant radiotherapy and chemotherapy are related to this increase. We studied the interrelationships among age at breast cancer diagnosis, interval to ANLL diagnosis, and survival in 54 women of whom 11 were from Kansas and 43 were from two other published series. Median age at breast cancer diagnosis was 50.5 years, median interval to ANLL diagnosis was 4.8 years, and median survival after ANLL diagnosis was 2.2 months. Increasing age was associated with a decrease of the interval to ANLL diagnosis just short of statistical significance (P = 0.0591). There was no association of survival with either age or the interval to ANLL diagnosis. With an increase in the use of adjuvant therapy in breast cancer there is a need to identify women at greatest risk of subsequently developing ANLL, at present not possible.

References

Carey R, HOLLAND J, Sheehe P, Graham S . Association of cancer of the breast and acute myelocytic leukemia. Cancer. 1967; 20(7):1080-8. DOI: 10.1002/1097-0142(196707)20:7<1080::aid-cncr2820200711>3.0.co;2-o. View

Cadman E, CAPIZZI R, Bertino J . Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer. 1977; 40(3):1280-96. DOI: 10.1002/1097-0142(197709)40:3<1280::aid-cncr2820400343>3.0.co;2-a. View

Rosner F, Carey R, Zarrabi M . Breast cancer and acute leukemia: report of 24 cases and review of the literature. Am J Hematol. 1978; 4(2):151-72. DOI: 10.1002/ajh.2830040207. View

Coleman C, Williams C, Flint A, Glatstein E, Rosenberg S, Kaplan H . Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med. 1977; 297(23):1249-52. DOI: 10.1056/NEJM197712082972303. View

Mansour E, Gray R, Shatila A, Osborne C, Tormey D, Gilchrist K . Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989; 320(8):485-90. DOI: 10.1056/NEJM198902233200803. View

Mehnert W, Haas J, Kittelmann B, Staneczek W, Mohner M, Kaldor J . A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms. IARC Sci Publ. 1986; (78):203-21. View

Haas J, Kittelmann B, Mehnert W, Staneczek W, Mohner M, Kaldor J . Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer. 1987; 55(2):213-8. PMC: 2002085. DOI: 10.1038/bjc.1987.40. View

Kingsley E, Durie B . Prolonged survival in patients with treatment-related leukemia. Scand J Haematol. 1986; 37(2):103-5. DOI: 10.1111/j.1600-0609.1986.tb01781.x. View

Herring M, Buzdar A, Smith T, Hortobagyi G, Blumenschein G . Second neoplasms after adjuvant chemotherapy for operable breast cancer. Am J Clin Oncol. 1986; 9(3):269-75. DOI: 10.1097/00000421-198606000-00018. View

10.

Fisher B, Rockette H, Fisher E, Wickerham D, Redmond C, Brown A . Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol. 1985; 3(12):1640-58. DOI: 10.1200/JCO.1985.3.12.1640. View

11.

Brenner B, Carter A, Sharon R, Tatarsky I . Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases. Oncology. 1984; 41(2):83-7. DOI: 10.1159/000225798. View

12.

Ershler W, Robins H, Davis H, Hafez G, Meisner L, Dahlberg S . Emergence of acute non-lymphocytic leukemia in breast cancer patients. Am J Med Sci. 1982; 284(2):23-31. DOI: 10.1097/00000441-198209000-00004. View

13.

Portugal M, FALKSON H, Stevens K, FALKSON G . Acute leukemia as a complication of long-term treatment of advanced breast cancer. Cancer Treat Rep. 1979; 63(2):177-81. View

14.

Foucar K, McKenna R, Bloomfield C, Bowers T, BRUNNING R . Therapy-related leukemia: a panmyelosis. Cancer. 1979; 43(4):1285-96. DOI: 10.1002/1097-0142(197904)43:4<1285::aid-cncr2820430416>3.0.co;2-j. View

15.

Gale R . Advances in the treatment of acute myelogenous leukemia. N Engl J Med. 1979; 300(21):1189-99. DOI: 10.1056/NEJM197905243002105. View

16.

Lerner H . Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer. Cancer Treat Rep. 1978; 62(8):1135-8. View